Journal of the European Academy of Dermatology and Venereology : JEADV
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.
Sonja Ständer, Sarina B Elmariah, Shawn G Kwatra, Gil Yosipovitch, Andrew E Pink, Soo Yeon Cheong, Xiaoxiao Chen, Zarif K Jabbar-Lopez, Liliana Ulianov, Christophe Piketty, Jonathan I Silverberg
Published: 202510.1111/jdv.70250
Abstract
BACKGROUND/OBJECTIVES: Itch is the most burdensome symptom in atopic dermatitis (AD) and prurigo nodularis (PN) and is associated with significant psychological distress, sleep deprivation and impaired quality of life. Achieving rapid control of itch…
Preview only. Read the full abstract at the source